Financhill
Back

Arcutis Biotherapeutics Vs. Madrigal Pharmaceuticals Industry Stock Comparison

Sell
39

ARQT
Arcutis Biotherapeutics

Last Price:
10.39
Seasonality Move:
-24.31%
Sell
47

MDGL
Madrigal Pharmaceuticals

Last Price:
233.33
Seasonality Move:
23.49%
Sell
39
Arcutis Biotherapeutics (ARQT) is a Sell

Is Arcutis Biotherapeutics a Buy, Sell or Hold?

  • The current Arcutis Biotherapeutics [ARQT] share price is $10.39. The Score for ARQT is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • ARQT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
47
Madrigal Pharmaceuticals (MDGL) is a Sell

Is Madrigal Pharmaceuticals a Buy, Sell or Hold?

  • The current Madrigal Pharmaceuticals [MDGL] share price is $233.33. The Score for MDGL is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • MDGL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ARQT Stock Price Chart

What is Arcutis Biotherapeutics's stock price today?

  • The Arcutis Biotherapeutics share price today is $10.39
    The current trend is moderately bullish and ARQT is experiencing slight buying pressure.

MDGL Stock Price Chart

What is Madrigal Pharmaceuticals's stock price today?

  • The Madrigal Pharmaceuticals share price today is $233.33
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MDGL is experiencing slight selling pressure.

ARQT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.23 Buy
Relative Strength Index (14 RSI): 53.01 Buy
Chaikin Money Flow: 469104 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (9.08 - 10.94) Buy
Bollinger Bands (100): (8.33 - 10.29) Buy

MDGL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -6.37 Sell
Relative Strength Index (14 RSI): 39.26 Sell
Chaikin Money Flow: -56242 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (236.75 - 253.29) Sell
Bollinger Bands (100): (225.94 - 277.64) Sell

ARQT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 10.53 Sell
20-day SMA: 10.33 Buy
50-day SMA: 9.91 Buy
200-day SMA: 8.15 Buy
8-day EMA: 10.45 Sell
20-day EMA: 10.28 Buy
50-day EMA: 9.91 Buy
200-day EMA: 8.95 Buy

MDGL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 235.51 Sell
20-day SMA: 243.56 Sell
50-day SMA: 258.23 Sell
200-day SMA: 242.61 Sell
8-day EMA: 236.38 Sell
20-day EMA: 242.2 Sell
50-day EMA: 250.62 Sell
200-day EMA: 239.83 Sell

Arcutis Biotherapeutics Earnings Growth & ARQT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.50 per share, an increase next quarter of $0.17 per share, an increase this year of $2.44 per share, and an increase next year of $0.39 per share.

Madrigal Pharmaceuticals Earnings Growth & MDGL Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $2.42 per share, an increase next quarter of $3.05 per share, a decrease this year of $9.33 per share, and an increase next year of $10.92 per share.

Arcutis Biotherapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Madrigal Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):